v3.26.3
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows From Operating Activities:    
Net income $ 90,821,000 $ 97,412,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 37,363,000 33,151,000
Equity in losses/(earnings) of unconsolidated investments 866,000 (512,000)
Distributions from unconsolidated investments 812,000 616,000
Unrealized (gains)/losses on marketable equity securities 7,610,000 (26,748,000)
Realized gains on sale of marketable securities (1,023,000) (872,000)
Gain on sale of property and equipment 0 (3,606,000)
Deferred income taxes 819,000 (2,600,000)
Stock–based compensation 5,285,000 3,499,000
Changes in operating assets and liabilities:    
Accounts receivable 15,516,000 2,877,000
Inventories (525,000) 1,195,000
Prepaid expenses and other assets 451,000 2,582,000
Operating lease obligations 916,000 524,000
Trade accounts payable (2,064,000) (2,926,000)
Accrued payroll 15,203,000 17,272,000
Amounts due to third party payors 1,824,000 (291,000)
Accrued risk reserves 5,170,000 10,416,000
Other current liabilities 22,828,000 30,250,000
Other noncurrent liabilities 4,719,000 832,000
Net cash provided by operating activities 204,953,000 168,271,000
Cash Flows From Investing Activities:    
Acquisition of skilled nursing facilities and other assets (54,698,000) 0
Investments in unconsolidated companies (7,983,000) (3,123,000)
Purchases of marketable securities (18,456,000) (56,953,000)
Proceeds from sale of marketable securities 22,683,000 64,689,000
Collections of notes receivable 0 512,000
Net cash used in investing activities (658,448,000) (20,924,000)
Cash Flows From Financing Activities:    
Borrowings under term loan and credit facility 530,000,000 0
Repayments under credit facility (67,937,000) (63,875,000)
Dividends paid to common stockholders (30,423,000) (28,773,000)
Issuance of common shares 20,766,000 9,415,000
Repurchase of common shares (24,672,000) (9,566,000)
Noncontrolling interest distributions (453,000) 0
Entrance fee deposits 348,000 64,000
Net cash provided by/(used in) financing activities 427,629,000 (92,735,000)
Net Increase/(Decrease) in Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents (25,866,000) 54,612,000
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning of Period 112,187,000 96,922,000
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, End of Period 86,321,000 151,534,000
Balance Sheet Classifications:    
Cash and cash equivalents 66,795,000 130,629,000
Restricted Cash and Cash Equivalents 19,526,000 20,905,000
Total Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents 86,321,000 151,534,000
Property and Equipment Excluding Real Estate Assets [Member]    
Cash Flows From Investing Activities:    
Purchases of property and equipment (35,654,000) (26,049,000)
Real Estate Assets [Member]    
Cash Flows From Investing Activities:    
Purchases of property and equipment $ (564,340,000) $ 0